GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!
Results Demonstrate Potential Protective Immunity Against Multiple SARS-CoV-2 Variants
We were having cocktails at a fancy restaurant last night with a hedge fund manager, who manages...
GeoVax Labs (GOVX) JP Morgan 2024 Healthcare Conference Transcript.
ILLUSTRATION 3 |MISSION AND STRATEGY
Our mission: One is to innovate. The other one is to differentiate. The other one is to accelerate and finally...
Revive Therapeutics (RVVTF) $0.02, Explores the Use of Bucillamine for Long COVID.
Bucillamine is one of the most amazing drugs (in our opinion), which was repurposed from its original use as an anti-inflammatory for use with...
Adding GeoVax (GOVX) $3.32 to Reverse Stock Split Watch List.
Okay, Here's Our First Name for the Reverse Stock Split, Watch List. We'll Venture to Have 10 Names Added to Watch List Within 30...
Adding Geovax (GOVX) to 2024 Biotech Watch List.
GEOVAX (GOVX) $0.32
We added this to the Watch List earlier in the week and then AFTER speaking to CEO David Dodd and the Head...
Bridging the Immunity Gap: An In-Depth Conversation with GeoVax’s (GOVX) CEO, David Dodd
In an era of rapid scientific development, the pharmaceutical industry constantly evolves to meet new challenges and seize emerging opportunities. GeoVax, a biotechnology company...
YIKES! New Form of Antimicrobial Resistance Discovered – One of the World’s Greatest Health...
A new mechanism has been discovered that enables bacteria to take up nutrients from their human host and bypass antibiotic treatment. This new form...
Provention Biosciences (PRVB) Enters the Danger Zone.
Chart Looks Beautiful - But Nervous is why, we use soft and dry.
LIVE QUOTE
We'll be short and sweet. We make no prediction as for...
VERU (VERU) $6.66, Goes Poof.
Veru Provides Update on FDA Advisory Committee Meeting
Market Cap Plunges from $1.9 Billion to $540 Million.
"In the long history of drug trials for patients...
Revive Therapeutics (RVVTF) Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company...
Latest article
Institutional Gold Analyst, 3rd Quarter Performance Update.
3rd Quarter Performance
3rd Quarter Report (29 Pages)
Top 5 Winners
Top 5 Losers
3rd Quarter Performance
3rd Quarter Profiles (29 Pages)
Click to view update
Top 5 Winners
Top 5 Losers...
Exclusive Interview with Dr. Sergei Diakov, from BCM Resources (B.V)
Up 169% Since Adding to Watch List:
Adding BCM Resources Corporation (B.V) to Watch List.
LIVE QUOTE
https://youtu.be/fq1nDVpOZVA?si=k0L2mibPn6d7-_6O
Crescat Capital YouTube Page
Mining Legends Review
Subscribe for full Watch List...
Fairchild Gold (FAIR.V) Advances Towards Drilling.
Fairchild Gold Advances Toward Drilling at Nevada Titan as Geophysics Sharpens Porphyry Targeting
Vancouver, British Columbia and Las Vegas, Nevada--(Newsfile Corp. - August 21, 2026)...
